Rankings
▼
Calendar
ORKA Q4 2021 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$28,000
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-4.73
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$55M
Total Liabilities
$4M
Stockholders' Equity
$51M
Cash & Equivalents
$53M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$28,000
-$16,000
-75.0%
Operating Income
-$6M
-$5M
-10.8%
Net Income
-$6M
-$5M
-10.8%
← FY 2021
All Quarters
Q1 2022 →